Sex-Specific miRNA Differences in Liquid Biopsies from Subjects with Solid Tumors and Healthy Controls

• Published in: Epigenomes Vol. 7; no. 1; p. 2
• Main Authors: Tomeva, Elena, Krammer, Ulrike D. B., Switzeny, Olivier J., Haslberger, Alexander G., Hippe, Berit
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10.01.2023; MDPI
• Subjects: Analysis; Bias; biomarkers; Biopsy; bladder; brain; Brain tumors; Brief Report; carcinogenesis; Colorectal cancer; Disease prevention; DNA methylation; Epigenetic inheritance; Epigenetics; females; Gastric cancer; Genetic aspects; health status; liquids; liver; Liver cancer; lungs; males; MicroRNA; MicroRNAs; miRNA; Pancreas; Pancreatic cancer; pancreatic neoplasms; patients; sample size; Sex; Solid tumors; Stomach; stomach neoplasms; Austria; sex dimorphism; CRC; DNA methylation; solid tumor; miRNA; cancer; biomarker; epigenetics; liquid biopsy
• ISSN: 2075-4655; 2075-4655
• DOI: 10.3390/epigenomes7010002

Dysregulation of epigenetic mechanisms has been recognized to play a crucial role in cancer development, but these mechanisms vary between sexes. Therefore, we focused on sex-specific differences in the context of cancer-based data from a recent study. A total of 12 cell-free DNA methylation targets in CpG-rich promoter regions and 48 miRNAs were analyzed by qPCR in plasma samples from 8 female and 7 male healthy controls as well as 48 female and 80 male subjects with solid tumors of the bladder, brain, colorectal region (CRC), lung, stomach, pancreas, and liver. Due to the small sample size in some groups and/or the non-balanced distribution of men and women, sex-specific differences were evaluated statistically only in healthy subjects, CRC, stomach or pancreas cancer patients, and all cancer subjects combined (n female/male—8/7, 14/14, 8/15, 6/6, 48/80, respectively). Several miRNAs with opposing expressions between the sexes were observed for healthy subjects (miR-17-5p, miR-26b-5p); CRC patients (miR-186-5p, miR-22-3p, miR-22-5p, miR-25-3p, miR-92a-3p, miR-16-5p); stomach cancer patients (miR-133a-3p, miR-22-5p); and all cancer patients combined (miR-126-3p, miR-21-5p, miR-92a-3p, miR-183-5p). Moreover, sex-specific correlations that were dependent on cancer stage were observed in women (miR-27a-3p) and men (miR-17-5p, miR-20a-5p). Our results indicate the complex and distinct role of epigenetic regulation, particularly miRNAs, depending not only on the health status but also on the sex of the patient. The same miRNAs could have diverse effects in different tissues and opposing effects between the biological sexes, which should be considered in biomarker research.